Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/285231 
Year of Publication: 
2021
Citation: 
[Journal:] Health Economics Review [ISSN:] 2191-1991 [Volume:] 11 [Issue:] 1 [Article No.:] 41 [Year:] 2021 [Pages:] 1-8
Publisher: 
Springer, Heidelberg
Abstract: 
Background: High-flow nasal cannula (HFNC) oxygen is a non-invasive ventilation system that was introduced as an alternative to CPAP (continuous positive airway pressure), with a marked increase in its use in pediatric care settings. This study aimed to evaluate the cost-effectiveness of early use of HFNC compared to oxygen by nasal cannula in an infant with bronchiolitis in the emergency setting. Methods: A decision tree model was used to estimate the cost-effectiveness of HFNC compared with oxygen by nasal cannula (control strategy) in an infant with bronchiolitis in the emergency setting. Cost data were obtained from a retrospective study on bronchiolitis from tertiary centers in Rionegro, Colombia, while utilities were collected from the literature. Results: The QALYs per patient calculated in the base-case model were 0.9141 (95% CI 0.913-0.915) in the HFNC and 0.9105 (95% CI 0.910-0.911) in control group. The cost per patient was US$368 (95% CI US$ 323-411) in HFNC and US$441 (95% CI US$ 384-498) per patient in the control group. Conclusions: HFNC was cost-effective HFNC compared to oxygen by nasal cannula in an infant with bronchiolitis in the emergency setting. The use of this technology in emergency settings will allow a more efficient use of resources, especially in low-resource countries with high prevalence of bronchiolitis.
Subjects: 
Health economics
Public health
Healthcare
Asthma
Oxygen
Cannula
Persistent Identifier of the first edition: 
Creative Commons License: 
cc-by Logo
Document Type: 
Article

Files in This Item:
File
Size
918.33 kB





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.